(Q46178331)

20 December 2017

title

Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe (English)

1 reference

20 December 2017

main subject

Zimbabwe

0 references

Schistosoma haematobium

0 references

1 reference

1 reference

F Mutapi

7

0 references

author name string

N Midzi

1

1 reference

20 December 2017

D Sangweme

2

1 reference

20 December 2017

S Zinyowera

3

1 reference

20 December 2017

M P Mapingure

4

1 reference

20 December 2017

K C Brouwer

5

1 reference

20 December 2017

N Kumar

6

1 reference

20 December 2017

G Woelk

8

1 reference

20 December 2017

T Mduluza

9

1 reference

20 December 2017

publication date

16 May 2008

1 reference

20 December 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

20 December 2017

volume

102

1 reference

20 December 2017

page(s)

759-766

1 reference

20 December 2017

issue

8

1 reference

20 December 2017

Genetic diversity of a population of Schistosoma haematobium derived from schoolchildren in east central Zimbabwe

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Praziquantel: is there real resistance and are there alternatives?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Day-to-day egg count fluctuation in Schistosoma mansoni infection and its operational implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Female genital schistosomiasis as a risk-factor for the transmission of HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Schistosomiasis: challenges for control, treatment and drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Drugs for the control of parasitic diseases: current status and development in schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Case report: Schistosoma mansoni infection: failure of standard treatment with praziquantel in a returned traveller

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Efficacy of praziquantel against Schistosoma mansoni in northern Senegal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

An international initiative on praziquantel use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Schistosoma mansoni: chemotherapy of infections of different ages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Schistosoma haematobium: population genetics of S. haematobium by direct measurement of parasite diversity using RAPD-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

Prevalence and distribution of schistosomiasis in Zimbabwe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.03.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSTMH.2008.03.010

1 reference

20 December 2017

PubMed ID

18486169

1 reference

20 December 2017